Related references
Note: Only part of the references are listed.Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance
A. H. Diacon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Delamanid for Multidrug-Resistant Pulmonary Tuberculosis
Maria Tarcela Gler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update
D. Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
Jose A. Caminero et al.
LANCET INFECTIOUS DISEASES (2010)
Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis
Evan W. Orenstein et al.
LANCET INFECTIOUS DISEASES (2009)
Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
James C. Johnston et al.
PLOS ONE (2009)
Treatment Outcomes and Long-term Survival in Patients with Extensively Drug-resistant Tuberculosis
Doh Hyung Kim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis
Yong Soo Kwon et al.
CLINICAL INFECTIOUS DISEASES (2008)
Extensively drug-resistant tuberculosis in California, 1993-2006
Ritu Banerjee et al.
CLINICAL INFECTIOUS DISEASES (2008)
Rapid Molecular Detection of Rifampicin Resistance Facilitates Early Diagnosis and Treatment of Multi-Drug Resistant Tuberculosis: Case Control Study
Philly O'Riordan et al.
PLOS ONE (2008)
Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis
Hye-Ryoun Kim et al.
CLINICAL INFECTIOUS DISEASES (2007)
Clinical and operational value of the extensively drug-resistant tuberculosis definition
G. B. Migliori et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
An intervention programme for the management of multidrug-resistant tuberculosis in France
Marie-Laure Uffredi et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study
C-Y. Chiang et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: A cohort study in the Philippines
Thelma E. Tupasi et al.
PLOS MEDICINE (2006)
Multidrug resistance among persons with tuberculosis in California, 1994-2003
RM Granich et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Does DOTS work in populations with drug-resistant tuberculosis?
K DeRiemer et al.
LANCET (2005)
Treatment of multidrug-resistant tuberculosis in San Francisco: An outpatient-based approach
M Burgos et al.
CLINICAL INFECTIOUS DISEASES (2005)
Drug-susceptibility testing in tuberculosis: Methods and reliability of results
SJ Kim
EUROPEAN RESPIRATORY JOURNAL (2005)
Treatment and outcome analysis of 205 patients with multidrug-resistant tuberculosis
ED Chan et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis
Y Shiraishi et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2004)
Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug resistant tuberculosis - Preliminary results of a retrospective study from Hong Kong
WW Yew et al.
CHEST (2003)
Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.
C Mitnick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome
HS Schaaf et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2003)
Quantifying heterogeneity in a meta-analysis
JPT Higgins et al.
STATISTICS IN MEDICINE (2002)
Treatment experience of multidrug-resistant tuberculosis in Florida, 1994-1997
M Narita et al.
CHEST (2001)
Clinical outcomes of Estonian patients with primary multidrug-resistant versus drug-susceptible tuberculosis
S Lockman et al.
CLINICAL INFECTIOUS DISEASES (2001)
Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens
WW Yew et al.
CHEST (2000)
Share Paper
